Combining lifestyle programs with drugs or supplements: cognitive benefits remain uncertain
A review found varied trials across dementia risk and early disease, but its abstract does not quantify cognitive benefits.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The authors suggest that combined lifestyle and pharmacological approaches may improve cognition when matched to appropriate participants and timing. However, the abstract offers no trial-level outcomes or pooled effect estimate. It therefore cannot show how much cognition changed, whether benefits were consistent, or whether combining approaches outperformed their individual components.
This abstract-based summary cannot establish dementia prevention: eligibility allowed cognitive outcomes as well as dementia-related measures, and the abstract does not report a reduction in new dementia diagnoses.
What counted as a combination
Programs paired several lifestyle elements, such as exercise, cognitive training or dietary guidance, with drugs, supplements or medical food. The included trials covered different stages of risk and disease, rather than a single uniform population.
Why trial details matter
The review emphasizes matching interventions to participants and improving trial methods. Without details of control groups, cognitive measures and individual results, a broad suggestion of benefit cannot identify a preferred program.
The original publication
Risk reduction and precision prevention across the Alzheimer's disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches.
Bereczki E, Mangialasche F, Barbera M et al.
J Prev Alzheimers Dis · 2025
- PubMed ID
- 41145344
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.